TERT-BUTYL 8-METHYL-3-(3-METHYL-1,2,4-THIADIAZOL-5-YL)-5,6-DIHYDRO(1,2,4)TRIAZOLO(4,3-A)PYRAZINE-7(8H)-CARBOXYLATE, (R)-
UNII XE3A96KK3A
Substance Identification & Data
This profile provides standardized clinical and technical data for Tert-butyl 8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazine-7(8h)-carboxylate, (r)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XE3A96KK3A.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1629229-88-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C14H20N6O2S YPGPEKQJPUMUNS-MRVPVSSYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Tert-butyl 8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazine-7(8h)-carboxylate, (r)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.